Elexacaftor-tezacaftor-ivacaftor (ETI) may improve bronchial dilatations in adolescents with cystic fibrosis (CF).

Late-onset asthma risk is associated with numerous lifestyle-related metabolites, particularly among women, according to study findings published in The Journal of Allergy and Clinical Immunology.

An automated AI-driven Diabetes Prevention Program (DPP) had noninferior outcomes with respect to weight, activity, and HbA1c compared with a human-led DPP.

A rare bird flu virus has claimed the life of a Washington state resident, making it the first known human case of this specific strain in the US.

Many Americans are bracing for higher medical costs in the new year and a growing number say those expenses are already shaping their decisions for care.

The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.

A new bipartisan bill in the Senate aims to protect federal wildland firefighters from working long, dangerous shifts with almost no protection from the thick smoke.

Peanut and IgE-mediated food allergy incidence in children significantly decreased since publication of early introduction guidelines in 2016.

For adults with VTE, continuing oral anticoagulants of at least 90 days is associated with a lower risk for recurrent VTE and a net clinical benefit.

Adding lactate trajectory classification into the SOFA score improved its accuracy in predicting mortality in sepsis-associated acute lung injury.

Older adults aged 75 to 79 receiving the bivalent RSV pre-F vaccine had greatly reduced hospital admission rates due to RSV-ARIs in the 2024-2025 RSV season.

Respiratory viruses continue to drive the majority of hospitalizations for bronchiolitis, pneumonia, and croup among children younger than 5 years.